[1] Fu JY, Wu CX, Shen SK, et al. Salivary gland carcinoma in Shanghai (2003-2012): an epidemiological study of incidence, site and pathology[J]. BMC Cancer, 2019, 19(1): 350. [2] Ali S, Sarhan M, Palmer FL, et al. Cause-specific mortality in patients with mucoepidermoid carcinoma of the major salivary glands[J]. Ann Surg Oncol, 2013, 20(7): 2396-2404. [3] Balachandran VP, Gonen M, Smith JJ, et al. Nomograms in oncology: more than meets the eye[J]. Lancet Oncol, 2015, 16(4): e173-e180. [4] Wang C, Yang C, Wang W, et al. A prognostic nomogram for cervical cancer after surgery from SEER database[J]. J Cancer, 2018, 9(21): 3923-3928. [5] Tang X, Zhou X, Li Y, et al. A novel nomogram and risk classification system predicting the cancer-specific survival of patients with initially diagnosed metastatic esophageal cancer: A SEER-based study[J]. Ann Surg Oncol, 2019, 26(2): 321-328. [6] Kong X, Li J, Cai Y, et al. A modified TNM staging system for non-metastatic colorectal cancer based on nomogram analysis of SEER database[J]. BMC Cancer, 2018, 18(1): 50. [7] 刘鹏弟,张亚飞,陆宏伟,等. 利用SEER数据库进行胃腺癌患者生存预后Nomogram图的构建[J].中国普外基础与临床杂志,2018,25(10):1183-1189. [8] Hayat MJ, Howlader N, Reichman ME, et al. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program [J]. Oncologist, 2007, 12(1): 20-37. [9] Daly MC, Paquette IM. Surveillance, epidemiology, and end results (SEER) and SEER-medicare databases: use in clinical research for improving colorectal cancer outcomes [J]. Clin Colon Rectal Surg, 2019, 32(1): 61-68. [10] Granic M, Suton P, Mueller D, et al. Prognostic factors in head and neck mucoepidermoid carcinoma: experience at a single institution based on 64 consecutive patients over a 28-year period [J]. Int J Oral Maxillofac Surg, 2018, 47(3): 283-288. [11] Byrd SA, Spector ME, Carey TE, et al. Predictors of recurrence and survival for head and neck mucoepidermoid carcinoma [J]. Otolaryngol Head Neck Surg, 2013, 149(3): 402-408. [12] 邓丽霞,廖文军,张石川,等.76例大涎腺粘液表皮样癌长期随访结果及预后分析[J].肿瘤预防与治疗,2018,31(3):183-188. [13] Chen MM, Roman SA, Sosa JA, et al. Histologic grade as prognostic indicator for mucoepidermoid carcinoma: a population-level analysis of 2400 patients [J]. Head Neck, 2014, 36(2): 158-163. [14] Xu W, Wang Y, Qi X, et al. Prognostic factors of palatal mucoepidermoid carcinoma: a retrospective analysis based on a double-center study [J]. Sci Rep, 2017, 7: 43907. [15] 罗佳,杨艳,杨森.唾液腺黏液表皮样癌的预后及影响因素分析[J].口腔医学,2017,37(1): 65-68. [16] Sultan I, Rodriguez-Galindo C, Al-Sharabati S, et al. Salivary gland carcinomas in children and adolescents: a population-based study, with comparison to adult cases [J]. Head Neck, 2011, 33(10): 1476-1481. [17] Goode RK, Auclair PL, Ellis GL. Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria [J]. Cancer, 1998, 82(7): 1217-1224. [18] Miyabe S, Okabe M, Nagatsuka H, et al. Prognostic significance of p27Kip1, Ki-67, and CRTC1-MAML2 fusion transcript in mucoepidermoid carcinoma: a molecular and clinicopathologic study of 101 cases [J]. J Oral Maxillofac Surg, 2009, 67(7): 1432-1441. [19] Shinomiya H, Ito Y, Kubo M, et al. Expression of amphiregulin in mucoepidermoid carcinoma of the major salivary glands: a molecular and clinicopathological study [J]. Hum Pathol, 2016, 57: 37-44. |